secwatch / observer
8-K filed November 2, 2022, 7:59 PM ET ticker AXIL CIK 0001718500
leadership confidence high sentiment positive materiality 0.60

Reviv3 Procare appoints Meenu Jain as CFO, replacing Christopher Go; $140k salary, 300k stock option

Axil Brands, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Meenu Jain

Chief Financial Officer
AXIL · Axil Brands, Inc.
Effective
2022-11-01
Filed
November 2, 2022, 7:59 PM ET
Effective November 1, 2022, Reviv3 Procare Company (the “Company”) its Board of Directors (the “Board”) appointed Meenu Jain as Chief Financial Officer of the Company, succeeding Christopher Go in such position.
Role change

Christopher Go

Secretary
AXIL · Axil Brands, Inc.
Effective
2022-11-01
Successor
Meenu Jain
Filed
November 2, 2022, 7:59 PM ET
Effective as of November 1, 2022, Christopher Go will continue to serve as Secretary of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Meenu Jain was appointed as Chief Financial Officer at Axil Brands, Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
Effective November 1, 2022, Reviv3 Procare Company (the “Company”) its Board of Directors (the “Board”) appointed Meenu Jain as Chief Financial Officer of the Company, succeeding Christopher Go in such position.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Christopher Go changed role as Secretary at Axil Brands, Inc..

Action
succeeded
Role
Secretary
Exact text from the filing
Effective as of November 1, 2022, Christopher Go will continue to serve as Secretary of the Company.
View on SEC.gov

Axil Brands, Inc. filing history →

Source: SEC EDGAR
accession 0001520138-22-000493
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.